273 related articles for article (PubMed ID: 23732959)
21. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease.
Ryu ES; Kim MJ; Shin HS; Jang YH; Choi HS; Jo I; Johnson RJ; Kang DH
Am J Physiol Renal Physiol; 2013 Mar; 304(5):F471-80. PubMed ID: 23283992
[TBL] [Abstract][Full Text] [Related]
22. Ameliorative effect of chrysin on adenine-induced chronic kidney disease in rats.
Ali BH; Adham SA; Al Za'abi M; Waly MI; Yasin J; Nemmar A; Schupp N
PLoS One; 2015; 10(4):e0125285. PubMed ID: 25909514
[TBL] [Abstract][Full Text] [Related]
23. Erhuang Formula ameliorates renal damage in adenine-induced chronic renal failure rats via inhibiting inflammatory and fibrotic responses.
Zhang CY; Zhu JY; Ye Y; Zhang M; Zhang LJ; Wang SJ; Song YN; Zhang H
Biomed Pharmacother; 2017 Nov; 95():520-528. PubMed ID: 28866419
[TBL] [Abstract][Full Text] [Related]
24. The flavonoid-rich fraction from rhizomes of Smilax glabra Roxb. ameliorates renal oxidative stress and inflammation in uric acid nephropathy rats through promoting uric acid excretion.
Wang S; Fang Y; Yu X; Guo L; Zhang X; Xia D
Biomed Pharmacother; 2019 Mar; 111():162-168. PubMed ID: 30579255
[TBL] [Abstract][Full Text] [Related]
25. Prolonged Pulmonary Exposure to Diesel Exhaust Particles Exacerbates Renal Oxidative Stress, Inflammation and DNA Damage in Mice with Adenine-Induced Chronic Renal Failure.
Nemmar A; Karaca T; Beegam S; Yuvaraju P; Yasin J; Hamadi NK; Ali BH
Cell Physiol Biochem; 2016; 38(5):1703-13. PubMed ID: 27160713
[TBL] [Abstract][Full Text] [Related]
26. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
27. The effect of sildenafil on rats with adenine-Induced chronic kidney disease.
Ali BH; Al Za'abi M; Adham SA; Al Suleimani Y; Karaca T; Manoj P; Al Kalbani J; Yasin J; Nemmar A
Biomed Pharmacother; 2018 Dec; 108():391-402. PubMed ID: 30236848
[TBL] [Abstract][Full Text] [Related]
28. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.
Yamada S; Tokumoto M; Tatsumoto N; Taniguchi M; Noguchi H; Nakano T; Masutani K; Ooboshi H; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1418-28. PubMed ID: 24808541
[TBL] [Abstract][Full Text] [Related]
29. Reduction of Serum Uric Acid Associated with Attenuation of Renal Injury, Inflammation and Macrophages M1/M2 Ratio in Hyperuricemic Mice Model.
Haryono A; Nugrahaningsih DAA; Sari DCR; Romi MM; Arfian N
Kobe J Med Sci; 2018 Oct; 64(3):E107-E114. PubMed ID: 30666040
[TBL] [Abstract][Full Text] [Related]
30. [Exploration on the establishment of animal models for gouty nephropathy complicated with chronic renal failure].
Xing RL; Meng DM; Ren W
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Oct; 31(10):1409-13. PubMed ID: 22097216
[TBL] [Abstract][Full Text] [Related]
31. Nephrotoxicity induced by a single dose of adenine: effects of 4-aminopyrazolo[3,4-d]pyrimidine and allopurinol.
Minami T; Nakagawa H; Ichii M; Kadota E; Okazaki Y
Biol Pharm Bull; 1994 Feb; 17(2):201-6. PubMed ID: 8205116
[TBL] [Abstract][Full Text] [Related]
32. Continuing exposure to low-dose nonylphenol aggravates adenine-induced chronic renal dysfunction and role of rosuvastatin therapy.
Yen CH; Sun CK; Leu S; Wallace CG; Lin YC; Chang LT; Chen YL; Tsa TH; Kao YH; Shao PL; Hsieh CY; Chen YT; Yip HK
J Transl Med; 2012 Jul; 10():147. PubMed ID: 22812704
[TBL] [Abstract][Full Text] [Related]
33. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
Panomvana D; Sripradit S; Angthararak S
J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
[TBL] [Abstract][Full Text] [Related]
34. Catalpol Attenuates Oxidative Stress and Inflammation via Mechanisms Involving Sirtuin-1 Activation and NF-κB Inhibition in Experimentally-Induced Chronic Kidney Disease.
Zaaba NE; Al-Salam S; Beegam S; Elzaki O; Yasin J; Nemmar A
Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615896
[TBL] [Abstract][Full Text] [Related]
35. Chronic exposure to environmental contaminant nonylphenol exacerbates adenine-induced chronic renal insufficiency: role of signaling pathways and therapeutic impact of rosuvastatin.
Yen CH; Lin KC; Leu S; Sun CK; Chang LT; Chai HT; Chung SY; Chang HW; Ko SF; Chen YT; Yip HK
Eur J Pharm Sci; 2012 Aug; 46(5):455-67. PubMed ID: 22484332
[TBL] [Abstract][Full Text] [Related]
36. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress.
Shen B; Hagiwara M; Yao YY; Chao L; Chao J
Hypertension; 2008 May; 51(5):1358-65. PubMed ID: 18391098
[TBL] [Abstract][Full Text] [Related]
37. Roflumilast alleviates adenine-induced chronic kidney disease by regulating inflammatory biomarkers.
Patel P; Patel S; Chudasama P; Soni S; Raval M
Eur J Pharmacol; 2023 Jun; 949():175731. PubMed ID: 37075855
[TBL] [Abstract][Full Text] [Related]
38. ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor-β/Smad3 signalling pathway in vivo and in vitro.
Wu X; Guan Y; Yan J; Liu M; Yin Y; Duan J; Wei G; Hu T; Weng Y; Xi M; Wen A
J Pharm Pharmacol; 2015 Aug; 67(8):1054-65. PubMed ID: 25864844
[TBL] [Abstract][Full Text] [Related]
39. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
[TBL] [Abstract][Full Text] [Related]
40. Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.
Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
Clin Pharmacol Ther; 2011 Sep; 90(3):392-8. PubMed ID: 21796116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
